Qiagen Takes Legal Action To Defend Quantiferon Intellectual Property

Reuters
03 Mar
March 3 (Reuters) - QIAGEN NV ::
*TAKES LEGAL ACTION TO DEFEND QUANTIFERON INTELLECTUAL PROPERTY AND PROTECT INNOVATIONS IN LATENT TUBERCULOSIS TESTING
*COMPLAINT, FILED IN LOCAL DIVISION OF COURT OF FIRST INSTANCE OF UNIFIED PATENT COURT $(UPC)$ IN DUESSELDORF, GERMANY, CONCERNS EUROPEAN PATENT EP 2 276 883 B2
*FILES LAWSUIT AGAINST BIOMÉRIEUX WITH GERMAN UNIFIED PATENT COURT TO PROTECT KEY INNOVATIONS IN ITS QUANTIFERON TECHNOLOGY

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 03-MAR-202506:00:00.247 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10